HCA Healthcare, Inc. (NYSE:HCA) Receives $515.77 Consensus Target Price from Analysts

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and sixteen have issued a buy recommendation on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $515.7727.

Several analysts have recently issued reports on the stock. Barclays reduced their price target on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Stephens cut their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Mizuho upped their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Finally, TD Cowen cut their target price on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, April 27th.

Check Out Our Latest Stock Analysis on HCA Healthcare

Hedge Funds Weigh In On HCA Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. State Street Corp boosted its holdings in shares of HCA Healthcare by 1.0% in the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after acquiring an additional 76,039 shares during the period. Capital World Investors boosted its holdings in shares of HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after acquiring an additional 40,086 shares during the period. Geode Capital Management LLC boosted its holdings in shares of HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after acquiring an additional 13,565 shares during the period. Norges Bank acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of HCA opened at $394.40 on Wednesday. The stock has a market capitalization of $87.49 billion, a PE ratio of 13.56, a P/E/G ratio of 1.25 and a beta of 1.18. HCA Healthcare has a 1 year low of $330.00 and a 1 year high of $556.52. The company’s 50-day simple moving average is $465.16 and its 200-day simple moving average is $483.77.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the prior year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts predict that HCA Healthcare will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is currently 10.73%.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Stories

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.